Wellthy Therapeutics, a diabetes management startup, has recently raised $4mn in a pre-Series A funding round from early-stage VC firm Saamna Capital. The recent funding in the startup comes after a two year gap when the company had raised seed funding from Ranjan Pai’s family office MEMG, according to an Entrackr report. In 2018, the…